Cauterization of the germinal nail matrix using phenol applications of differing durations: a histologic study.
BACKGROUND
Phenol has been used for more than 60 years in the treatment of ingrown toenails. Many reports have documented the safety and effectiveness of phenol matricectomy, although with variable treatment application times.


OBJECTIVE
We performed research to determine the application time required for phenol matricectomy for complete denaturation of the nail matrix to occur at a concentration of 88%. Identifying the optimal time required to destroy the germinal matrix without causing further soft-tissue damage should reduce the potential for complications.


METHODS
Thirty anatomic cadaveric fresh hallux samples were used to perform phenol matricectomy. The applications were for 1 to 6 minutes using 10 samples per time point and analyzed by hematoxylin-eosin staining to determine the presence or absence of the basal or germinal layer of the nail bed epithelium (NBE).


RESULTS
After a 1-minute application of 88% phenol solution, only superficial damage to the NBE was noted, with the basal layer primarily intact. After a 2-minute application, the nail plate was avulsed with a thin basal layer remaining. After a 3-minute application, full-thickness necrosis of the NBE was noted in 6 of the 10 specimens. After 4-, 5-, and 6-minute applications, full-thickness necrosis of the NBE was noted and the basal layer was completely destroyed in all 30 specimens.


CONCLUSIONS
The study was performed in cadaveric fresh specimens.


CONCLUSIONS
Application of 88% phenol solution for at least 4 minutes is necessary for complete destruction of the nail matrix, creating an environment that avoids nail regrowth.
Escuela Universitaria de Enfermería, Fisioterapia y Podología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. ribebeva@enf.ucm.es
Ricardo
R
Becerro de Bengoa Vallejo
Marta Elena
ME
Losa Iglesias
Fermin
F
Viejo Tirado
Rosario
R
Serrano Pardo
D002102:Cadaver; D004305:Dose-Response Relationship, Drug; D004817:Epidermis / Q000187:drug effects* / Q000473:pathology; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D005404:Fixatives; D005557:Formaldehyde; D006801:Humans; D009262:Nails / Q000187:drug effects* / Q000473:pathology; D009263:Nails, Ingrown / Q000473:pathology / Q000628:therapy*; D019800:Phenol / Q000494:pharmacology*; D012597:Sclerosing Solutions / Q000494:pharmacology*
D005404:Fixatives; D012597:Sclerosing Solutions; D005557:Formaldehyde; D019800:Phenol